111 Beheer

Beheer criteriumcontroles 2/4

De CEO 111 is Junling Liu, benoemd in Jan2015, heeft een ambtstermijn van 9.83 jaar. bezit rechtstreeks 21.67% van de aandelen van het bedrijf, ter waarde $ 11.35M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6 jaar en 6.2 jaar.

Belangrijke informatie

Junling Liu

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	9.8yrs
Eigendom CEO	21.7%
Management gemiddelde ambtstermijn	6yrs
Gemiddelde ambtstermijn bestuur	6.2yrs

Recente managementupdates

Recent updates

111, Inc.: Undervalued After Recent Unjustified Share Price Collapse; 50% Upside

Aug 18

Is 111 (NASDAQ:YI) A Risky Investment?

Apr 09

Could The 111, Inc. (NASDAQ:YI) Ownership Structure Tell Us Something Useful?

Mar 05

Did You Miss 111's (NASDAQ:YI) 70% Share Price Gain?

Jan 29

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Dec 25

Why 111, Inc. (NASDAQ:YI) Could Be Worth Watching

Dec 04

111 reports Q3 results, provides Q4 revenue guidance

Nov 19

111, Inc.: Cheap But Risky And Controlled By Founders

Nov 16

CEO

Junling Liu (59 yo)

9.8yrs

Tenure

Mr. Junling Liu is Co-founder of 111, Inc. and has been its Chairman and Chief Executive Officer since 2015. Mr. Liu has been Co-Chairman of 111, Inc. since September 2018. He serves as An Acting Chief Fin...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Gang Yu	Co-Founder & Executive Chairman	9.8yrs	geen gegevens	21.05% $ 11.0m
Junling Liu	Co-Founder	9.8yrs	geen gegevens	21.67% $ 11.4m
Haihui Wang	Co-Chief Operating Officer	6yrs	geen gegevens	geen gegevens
Pengcheng Zhu	Co-Chief Operating Officer	6yrs	geen gegevens	geen gegevens
Monica Mu	IR Director	no data	geen gegevens	geen gegevens
Anfeng Guo	Chief Innovation Officer	4.5yrs	geen gegevens	geen gegevens
Alex Liu	Finance Director	no data	geen gegevens	geen gegevens

6.0yrs

Gemiddelde duur

Ervaren management: Het managementteam van YI is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Gang Yu	Co-Founder & Executive Chairman	9.8yrs	geen gegevens	21.05% $ 11.0m
Junling Liu	Co-Founder	9.8yrs	geen gegevens	21.67% $ 11.4m
Jian Sun	Independent Director	6.2yrs	geen gegevens	geen gegevens
Jun Luo	Independent Director	6.2yrs	geen gegevens	geen gegevens
Yang Chen	Director	no data	geen gegevens	geen gegevens
Teo Nee Chuan	Independent Director	6.2yrs	geen gegevens	geen gegevens

6.2yrs

Gemiddelde duur

57.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van YI wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.2 jaar).

111 Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

111, Inc. Announces Board Changes

Insufficient new directors

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Insufficient new directors

111, Inc. Announces Management Changes

Recent updates

111, Inc. Announces Board Changes

111, Inc. to Report Q3, 2024 Results on Nov 28, 2024

111, Inc. Announces Receipt of Notification from Nasdaq

111, Inc. Announces Receipt of Notification from Nasdaq

A Look At The Intrinsic Value Of 111, Inc. (NASDAQ:YI)

111, Inc. to Report Q2, 2024 Results on Aug 29, 2024

111, Inc. announced delayed 20-F filing

111, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

New minor risk - Share price stability

Third quarter 2023 earnings released

111, Inc. to Report Q3, 2023 Results on Nov 30, 2023

Second quarter 2023 earnings released: CN¥0.68 loss per share (vs CN¥1.14 loss in 2Q 2022)

111, Inc. to Report Q2, 2023 Results on Aug 24, 2023

First quarter 2023 earnings released: CN¥0.38 loss per share (vs CN¥1.33 loss in 1Q 2022)

111, Inc. to Report Q1, 2023 Results on Jun 15, 2023

Full year 2022 earnings released: CN¥5.00 loss per share (vs CN¥8.08 loss in FY 2021)

Third quarter 2022 earnings released: CN¥1.16 loss per share (vs CN¥3.05 loss in 3Q 2021)

Insufficient new directors

111, Inc. to Report Q3, 2022 Results on Dec 01, 2022

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Second quarter 2022 earnings released

111, Inc. Provides Revenue Guidance

111 Non-GAAP EPS of -$0.14, revenue of $453.4M

111, Inc. to Report Q2, 2022 Results on Aug 25, 2022

111, Inc.'s Inexorable Drive Towards Profitability

First quarter 2022 earnings released

Insufficient new directors

111, Inc. to Report Q1, 2022 Results on Jun 16, 2022

Full year 2021 earnings: Revenues in line with analyst expectations

111, Inc. to Report Q4, 2021 Results on Mar 17, 2022

Third quarter 2021 earnings released

Solid Earnings, Modest Buyback Fail To Boost Drug Seller 111, Inc.

111, Inc. (NasdaqGM:YI) announces an Equity Buyback for $10 million worth of its shares.

Second quarter 2021 earnings released

111, Inc. Provides Preliminary Revenue Guidance for the Third Quarter of 2021

Health Check: How Prudently Does 111 (NASDAQ:YI) Use Debt?

111, Inc.: Undervalued After Recent Unjustified Share Price Collapse; 50% Upside

First quarter 2021 earnings released: CN¥1.77 loss per share (vs CN¥1.52 loss in 1Q 2020)

111, Inc. Provides Revenue Guidance for the Second Quarter of 2021

Full year 2020 earnings released: CN¥5.54 loss per share (vs CN¥6.11 loss in FY 2019)

Is 111 (NASDAQ:YI) A Risky Investment?

Full year 2020 earnings released: CN¥5.54 loss per share (vs CN¥6.11 loss in FY 2019)

111, Inc. Provides Earnings Guidance for the First Quarter of 2021

Could The 111, Inc. (NASDAQ:YI) Ownership Structure Tell Us Something Useful?

111, Inc. to Report Q4, 2020 Results on Mar 18, 2021

111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services

New 90-day high: US$12.70

Did You Miss 111's (NASDAQ:YI) 70% Share Price Gain?

New 90-day high: US$7.62

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Why 111, Inc. (NASDAQ:YI) Could Be Worth Watching

Third quarter 2020 earnings released: CN¥1.32 loss per share

111 reports Q3 results, provides Q4 revenue guidance

111, Inc.: Cheap But Risky And Controlled By Founders

New 90-day high: US$7.45

111, Inc. Announces Management Changes

111, Inc. and Shanghai Uniondrug Information Technology Join Hands to Advance Innovation in Commercial Insurance Payment

New 90-day low - US$5.96

First half earnings released

111, Inc. to Report Q2, 2020 Results on Aug 20, 2020

New 90-day low - US$6.14

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd